Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259566 · ClinicalTrials.gov registry record · NA
Potential Impact of Menthol Ban in Cigarettes and E-cigarettes
A NA study of Tobacco Smoking, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05259566: Active NA study of Tobacco Smoking, sponsored by Yale University.
NCT05259566 is a NA study of Tobacco Smoking that is active but no longer recruiting, run by Yale University. The registered enrollment target is 150 participants, below the 473-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05259566, a NA study of Tobacco Smoking, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Menthol cigarette use remains a major public health problem and the FDA has proposed to ban menthol in cigarettes. However, additional evidence is needed to understand whether menthol flavor in e-cigarettes is important for harm reduction among menthol cigarette smokers in the context of a menthol cigarette ban. The primary aim of this project is to understand how the availability of menthol vs tobacco flavor e-cigarettes influences switching and reduces smoking behavior among adults who currently smoke menthol cigarettes to understand the potential effects in the context of a ban of menthol cigarettes.
Primary Outcome
Participants will report the total number of cigarettes consumed each day using the well-validated timeline follow-back (TLFB) interview methods to assess change.
Conditions Studied
Interventions
- BEHAVIORAL menthol ban in cigarettes only
- BEHAVIORAL total menthol ban
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT05259566 still lists
NCT05259566 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Tobacco Smoking appearing as the primary indexed condition, and to 2 interventions - of which menthol ban in cigarettes only is the first listed.
NCT05259566 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05259566 about?
NCT05259566 is a clinical study titled "Potential Impact of Menthol Ban in Cigarettes and E-cigarettes". Menthol cigarette use remains a major public health problem and the FDA has proposed to ban menthol in cigarettes. However, additional evidence is needed to understand whether menthol flavor in e-cigarettes is important for harm reduction among menthol cigarette smokers in the context of a menthol c...
What is the current status of trial NCT05259566?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-12-01. Estimated completion is 2026-03-31.
What conditions does trial NCT05259566 study?
This clinical trial studies the following conditions: Tobacco Smoking.
What interventions are being tested in trial NCT05259566?
The interventions under investigation include: menthol ban in cigarettes only (BEHAVIORAL), total menthol ban (BEHAVIORAL).
Who is sponsoring clinical trial NCT05259566?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05259566 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05259566's enrollment target sits among peer trials
150 13th of 38 higher than 26 of 38 other Tobacco Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI